Navigation

In the News

Articles represent the views of their authors and not necessarily those of ME/CFS Australia. Some links lead to articles on third party websites.

21 March, 2026Australia

Miranda Hart Reveals She Has Hurt Her Ankle And Can't Walk Properly As She Opens Up About Her Anxiety Over Her Extreme Fear Of Healthcare

Miranda Hart has revealed she has hurt her ankle and can't walk properly as she opened up about her anxiety over her extreme fear of healthcare. In her 2024 autobiography, the comedian, 53, best known for her BBC sitcom Miranda, recounted her three-decade battle that 'left her bedbound and without joy'. Initially diagnosed with agoraphobia, she later learned that undiagnosed Lyme disease had developed into chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME).

21 March, 2026Australia

Glenmark Launches Milnacipran Generic, Tapping $103M Market

Glenmark Pharmaceuticals USA announced the launch of Milnacipran Hydrochloride Tablets on March 19, 2026. This new generic enters a market where the reference product, Savella®, recorded approximately $102.9 million in sales over the 12 months leading up to January 2026.

21 March, 2026Australia

Pre-Pandemic Symptom Visits Linked To Higher Odds Of Post-COVID, Study Finds

Women who frequently sought health care for recurring symptoms before the pandemic were more likely to later be diagnosed with post-COVID, according to a thesis from the University of Gothenburg.

20 March, 2026Australia

Breckenridge Announces Launch Of Milnacipran HCl Tablets, Generic Equivalent Of Savella®

Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, has announced the launch of Milnacipran HCl Tablets, the generic equivalent of Savella® by AbbVie, in the pain management category.

20 March, 2026Australia

Ontario Woman Has Spent 5½ Dark Years With Long COVID

Nancy Perez contracted COVID-19 in December 2020 and has never recovered.

20 March, 2026Australia

Health Seeking Before Pandemic Linked To Post-COVID

Women in Sweden who frequently sought healthcare for recurring symptoms before the pandemic were more likely to later be diagnosed with post-COVID, according to a thesis at the University of Gothenburg.

19 March, 2026Australia

Comparison Of Serum 25-Hydroxyvitamin D Levels Between Patients With Multiple Chemical Sensitivity And Healthy Controls: A Case–Control Study

This study aimed to compare serum 25-hydroxyvitamin D (25[OH]D) concentrations between patients with MCS and healthy controls.

19 March, 2026Australia

WOMEN’S SOCCER HISTORY MONTH (Day 16): Michelle Akers: Soccer’s Iron Woman (1999)

Michelle Akers overcame so much as one of the greatest women’s soccer players of all time.

19 March, 2026Australia

Swedish Study Reveals COVID-19 May Increase Glandular Fever Risk

Even individuals who did not become seriously ill with COVID-19 may have developed a weakened immune system that could lead to serious illnesses in the future. Research from Örebro University suggests that the coronavirus might have had more far-reaching effects than previously believed.

18 March, 2026Australia

Scientists Identify Common Symptom Patterns In Post-COVID-19 Vaccination Syndrome

A large Japanese registry study identifies common symptom patterns and recovery timelines in patients with persistent post-COVID-19 vaccination symptoms, offering new insight into how these rare but complex conditions may be monitored and managed.

18 March, 2026Australia

“Advocating For Myself At KCL Feels Like A Full-Time Job”: Disabled Students Share Their Experiences At King’s.

Members of King’s College London’s (KCL) Disabled Student Society and other students with seen and unseen disabilities have publicly spoken out about their experiences at King’s.

18 March, 2026Australia

Long COVID In India: Clinical Patterns, Challenges And Implications For Infectious Diseases Specialists

India’s COVID-19 burden has transitioned from acute pandemic management to long-term sequelae care.